Structure Therapeutics, Inc. Sponsored ADR (GPCR)
NASDAQ:GPCR
Technical Sentiment
Overall Consensus
Sell
8Bullish
2Neutral
12Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) Moving Averages Convergence Divergence (MACD) indicator is -5.78, suggesting Structure Therapeutics, Inc. Sponsored ADR is a Buy.
Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) 20-Day exponential moving average is 54.17, while Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) share price is $45.92, making it a Sell.
Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) 50-Day exponential moving average is 60.52, while Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) share price is $45.92, making it a Sell.
Structure Therapeutics, Inc. Sponsored ADR (GPCR) Pivot Points
Classic
43.09
44.55
45.37
46.83
47.65
49.11
49.93
Fibonacci
44.55
45.42
45.96
46.83
47.70
48.24
49.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Structure Therapeutics, Inc. Sponsored ADR (GPCR) Moving Averages
MA5
47.27Sell
47.40Sell
MA10
50.01Sell
49.69Sell
MA20
54.39Sell
54.17Sell
MA50
69.10Sell
60.52Sell
MA100
60.38Sell
57.36Sell
MA200
41.26Buy
44.26Buy
Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) 10-Day exponential moving average is 49.69, while Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) share price is $45.92, making it a Sell.
Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) 100-Day exponential moving average is 57.36, while Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) share price is $45.92, making it a Sell.
Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) stock price is $45.92 and Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) 50-day simple moving average is 69.10, creating a Sell signal.
Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) stock price is $45.92 and Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) 100-day simple moving average is 60.38, creating a Sell signal.
Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) stock price is $45.92 and Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) 200-day simple moving average is 41.26, creating a Buy signal.
Structure Therapeutics, Inc. Sponsored ADR (GPCR) Technical Indicators
RSI (14)
24.95
Buy
STOCH (9,6)
6.64
Buy
STOCHRSI (14)
5.96
Buy
MACD (12,26)
-5.78
Buy
ADX (14)
41.15
Neutral
Williams %R
-93.00
Buy
CCI (14)
-124.81
Buy
ATR (14)
3.41
-
Ultimate Oscillator
33.63
Neutral
ROC
-18.73
Sell
Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) Relative Strength Index (RSI) is 24.95, creating a Buy signal.
Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) Trend Strength Indicator (ADX) is 41.15, creating a Neutral signal.
Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) Commodity Channel Index (CCI) is -124.81, creating a Buy signal.
Structure Therapeutics, Inc. Sponsored ADR’s (GPCR) Price Rate of Change (ROC) is -18.73, creating a Sell signal.
FAQ
Is GPCR a Buy, Hold, or Sell?
Based on GPCR’s technical indicators, GPCR is a Sell.
What is GPCR’s RSI (14)?
GPCR’s RSI (14) is 24.95, which suggests GPCR is a Buy.
What is GPCR’s MACD?
GPCR’s MACD is -5.78, which suggests GPCR is a Buy.
What is GPCR’s 5-day moving average?
GPCR’s 5-day moving average is 47.27, which suggests GPCR is a Sell.
What is GPCR’s 20-day moving average?
GPCR 20-day moving average is 54.39, which suggests GPCR is a Sell.
What is GPCR’s 50-day moving average?
GPCR’s 50-day moving average is 69.10, which suggests GPCR is a Sell.
What is GPCR’s 200-day moving average?
GPCR’s 200-day moving average is 41.26, which suggests GPCR is a Buy.
What is GPCR’s Williams % R (14)?
GPCR’s Williams % R (14) is -93.00, which suggests GPCR is a Buy.
What is GPCR’s CCI (14)?
GPCR’s CCI (14) is -124.81, which suggests GPCR is a Buy.